Skip to main content

Animations

MJFF Publications

4211 - 4220 of 8100 Results
Title
Year
  • Year
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • RESTRICTED
    Title: "Eine Impfung wäre viel praktischer als die Infusion von Antikörpern"
    Journal Name: InFo Neurologie + Psychiatrie
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s15005-020-1426-y
    Best OA location URL:
    Citation Count: 0
  • RESTRICTED
    Title: Expanding phenomenologic heterogeneity of tardive syndromes: Time for an updated assessment tool
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.023
    Best OA location URL:
    Citation Count: 5
  • RESTRICTED
    Title: Genome-Wide Association Study Meta-Analysis of Stroke in 22 000 Individuals of African Descent Identifies Novel Associations With Stroke
    Journal Name: Stroke
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1161/strokeaha.120.029123
    Citation Count: 29
  • OPEN
    Title: Incidence and risk factors for seizures associated with deep brain stimulation surgery
    Journal Name: Journal of Neurosurgery
    Publisher: Journal of Neurosurgery Publishing Group (JNSPG)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3171/2020.5.jns20125
    Citation Count: 14
  • RESTRICTED
    Title: Infusion Therapies for Parkinson’s Disease
    Journal Name: Current Neurology and Neuroscience Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s11910-020-01062-2
    Best OA location URL:
    Citation Count: 12
  • RESTRICTED
    Title: Novel fluid biomarkers to differentiate frontotemporal dementia and dementia with Lewy bodies from Alzheimer's disease: A systematic review
    Journal Name: Journal of the Neurological Sciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jns.2020.116886
    Citation Count: 16
  • OPEN
    Title: Screening non-MAPT genes of the Chr17q21 H1 haplotype in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.07.022
    Citation Count: 16
  • RESTRICTED
    Title: The Coronavirus Disease 2019 Crisis as Catalyst for Telemedicine for Chronic Neurological Disorders
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2020.1452
    Citation Count: 183
  • RESTRICTED
    Title: The UPRosome – decoding novel biological outputs of IRE1α function
    Journal Name: Journal of Cell Science
    Publisher: The Company of Biologists
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1242/jcs.218107
    Citation Count: 38
  • OPEN
    Title: Ursodeoxycholic acid as a novel disease-modifying treatment for Parkinson’s disease: protocol for a two-centre, randomised, double-blind, placebo-controlled trial, The 'UP' study
    Journal Name: BMJ Open
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1136/bmjopen-2020-038911
    Citation Count: 27
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.